Our research will focus over the next five years on:
- The role of FGL2/fibroleukin in human and experimental viral hepatitis
- The role of tissue factor and FGL2 in xenograft rejection (funded by the Heart and Stroke Foundation of Canada, co-investigator Dr. D. Grant)
- CIHR Group Grant 'Cellular and Molecular Basis of Organ Injury.' Dir: Dr. G. Levy and 5 principal investigators Drs. G. Downey, O. Rotstein, P. Marsden, L. Zhang, and M. Cybulsky. The group was first funded by CIHR 10 years ago and the focus of the work is to: 1) promote scientific excellence and advance the state of knowledge in organ injury; 2) to promote research to allow advances to move from the bench to the bedside; and 3) to foster an environment for the training of future scientific leaders.